They might need more frequent or higher doses to stay healthy and ensure their babys health too
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read TB-500 Peptide: Benefits, Uses, Side Effects, Dosage, and Research
Activates cell migration and angiogenesis pathways
This product is not a drug, food, cosmetic, or dietary supplement, has not been evaluated or approved by the FDA, and is not intended to diagnose, treat, cure or prevent any disease